8/22/2006

India's Ranbaxy Laboratories reportedly is making a $100 million bid for Russian generic drugs maker Akrikhin. A Ranbaxy official declined comment on the move, but acknowledged the firm is "actively looking at acquisition opportunities in USA, Europe and emerging markets."

Related Summaries